PetMed Express (PETS)
(Delayed Data from NSDQ)
$3.90 USD
+0.04 (1.04%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $3.90 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
B Value C Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$3.90 USD
+0.04 (1.04%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $3.90 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
B Value C Growth D Momentum B VGM
Zacks News
Merit Medical Deserves a Place in Your Portfolio: Here's Why
by Zacks Equity Research
A slew of bolt-on acquisitions leverages Merit Medical (MMSI) to drive inorganic growth.
Build a Christmas Tree with Top-Ranked Stocks
by Sweta Killa
As Christmas tree symbolizes good tidings, let's build a similar tree for stock-loving investors that could rake in big gains in 2018.
5 Reasons Why You Should Buy Baxter (BAX) Stock Right Now
by Zacks Equity Research
Baxter (BAX) has been gaining on the back of favorable developments in the regulatory front and product launches.
Top Ranked Growth Stocks to Buy for December 22nd
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, December 22nd:
Intuitive Surgical Banks on da Vinci X, Forex Woes Remain
by Zacks Equity Research
Intuitive Surgical's (ISRG) consistent efforts to boost da Vinci X platform is a positive. However, foreign exchange movements are impacting the company's results
Amazon (AMZN) Plans to Snap Up Cybersecurity Startup Sqrrl
by Zacks Equity Research
Amazon.com, Inc. (AMZN) to reportedly acquire a cyber security startup, Sqrrl Data Inc.
Amazon (AMZN) Gears Up for 2nd Digital Day Sale on Dec 29
by Zacks Equity Research
Amazon (AMZN) announces second Digital Day sale on Dec 29. Customers will get attractive offers on digital content.
Cypress (CY) Adds Jeannine Sargent to its Board of Directors
by Zacks Equity Research
Cypress Semiconductor Corp. (CY) adds Jeannine Sargent to its board.
Ecolab, Cargill and Techstars Launch Accelerator Program
by Zacks Equity Research
Ecolab (ECL) continues to focus on investment in key businesses and bolt-on acquisitions to gain market traction and boost profits.
Top Ranked Growth Stocks to Buy for December 19th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, December 19th:
Bull Of The Day: PetMed Express (PETS)
by Brian Bolan
The victim of a short attack is seeing estimates increase and 30% of the float is sold short
Amazon Eases off Eleventh Hour Shopping With Exciting Offers
by Zacks Equity Research
Amazon (AMZN) recently extends its deadline for free shipping and makes last- minute holiday shopping an easy ride for its customers.
Teleflex (TFX), HealthTrust Rebond on Respiratory Products
by Zacks Equity Research
Teleflex's (TFX) exclusive contracts with HealthTrust provide benefits to the latter with an opportunity to consolidate its members' respiratory purchases with the same supplier.
Walgreens Closes PharMerica Buyout as KKR's Minority Partner
by Zacks Equity Research
Walgreens (WBA) along with privately-held global investment firm KKR completes the acquisition of Pharmerica for $1.4 billion. The merger agreement was announced in August.
Genomic Health at a 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Genomic Health (GHDX) forges ahead with deals to strengthen hold in the high-potential prostate cancer therapeutics market.
Here's Why You Should Bet on WESCO International (WCC) Stock
by Zacks Equity Research
WESCO International, Inc. (WCC) continues to perform well, driven by differentiated products, strength across all end markets, improved execution and positive pricing.
Myriad Genetics Presents Favorable EMBRACA Trial Results
by Zacks Equity Research
Myriad Genetics (MYGN) adopts initiatives to boost uptake of BRACAnalysis CDx test.
Wright Medical (WMGI) Acquires IMASCAP SAS for $88.8 Million
by Zacks Equity Research
Wright Medical's (WMGI) acquisition of IMASCAP SAS will strengthen Extremities business.
Adobe (ADBE) Beats on Q4 Earnings, Issues Guidance for 2018
by Zacks Equity Research
Adobe Systems Inc. (ADBE) reports strong fiscal fourth-quarter results, driven by robust growth in its cloud-based subscription products.
Here's Why You Should Invest in Illumina (ILMN) Stock Now
by Zacks Equity Research
Illumina (ILMN) banks on product launches and international market prospects.
Myriad Genetics Rides on Solid Molecular Diagnostics Suite
by Zacks Equity Research
Myriad Genetics (MYGN) adopts initiatives to boost the Molecular Diagnostics portfolio.
CVS Health Banks on Solid Pharmacy Services, Competition Rife
by Zacks Equity Research
CVS Health's (CVS) strong 2018 PBM selling season buoys optimism.
6 Reasons to Invest in Beacon Roofing (BECN) Stock Right Now
by Zacks Equity Research
Beacon Roofing Supply (BECN) is witnessing strong sales growth within each of its three product lines and geographies. This is projected to continue in fiscal 2018 as well.
NuVasive (NUVA) to Acquire SafePassage, Strengthens IONM
by Zacks Equity Research
NuVasive's (NUVA) combined entity with SafePassage seems strategic as the move will fortify the NuVasive Clinical Services' (NCS) status as the largest U.S. provider of outsourced IONM services.
Top Ranked Growth Stocks to Buy for December 14th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, December 14th: